| |
Clinilabs’ Clinical Research Unit (CRU) is a 48-bed, state-of-the-art facility located in the heart of New York City that offers our clients access to a seasoned clinical development team.  We execute early-phase and specialty studies with care, recruiting patients and normal healthy subjects from a diverse metropolitan population of over 19 million people. The CRU provides complete support for all types of pharmacokinetic, bioavailability, bioequivalence, and drug/food interaction studies, and we are particularly experienced in the conduct of complex studies that involve pharmacodynamic assessments or biomarkers. From the first study synopsis to the completion of the final clinical study report, we offer a complete continuum of CRU services.
Clinilabs’ CRU conducts studies in all therapeutic areas, and has special expertise and facilities for CNS, cardiovascular, and endocrine/metabolic research. Go to “Specialty CRU Services” for highlights regarding these offerings.
|
